No black box warning on record for Adefovir Dipivoxil

As of the latest FDA labeling reviewed, Adefovir Dipivoxil (ADEFOVIR DIPIVOXIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Adefovir Dipivoxil medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Severe acute exacerbations of hepatitis: Monitor hepatic function closely at repeated intervals for at least several months in patients who discontinue adefovir dipivoxil. ( 5.1 ) Nephrotoxicity: Monitor renal function during therapy for all patients, particularly those with pre-existing or other risks for renal impairment. Dose adjustment may be required. ( 5.2 ) HIV Re

No black box warning on record for Adefovir Dipivoxil

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Severe acute exacerbations of hepatitis: Monitor hepatic function closely at repeated intervals for at least several months in patients who discontinue adefovir dipivoxil. ( 5.1 ) Nephrotoxicity: Monitor renal function during therapy for all patients, particularly those with pre-existing or other risks for renal impairment. Dose adjustment may be required. ( 5.2 ) HIV Re

Adefovir Dipivoxil Black Box Warning

No black box warning on record for Adefovir Dipivoxil

Other warnings & precautions

Adefovir Dipivoxil Black Box Warning

No black box warning on record for Adefovir Dipivoxil

Other warnings & precautions